Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4892)
All Articles published online
|
Sep 21, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Choe WH, Kim YJ, Park HS, Park SW, Kim JH, Kwon SY. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(35): 12588-12594 [PMID: PMC4168095 DOI: 10.3748/wjg.v20.i35.12588] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i35/12588.htm |
| Number | Citing Articles |
| 1 |
Feng Duan, Yan-Hua Bai, Li Cui, Xiao-Hui Li, Jie-Yu Yan, Mao-Qiang Wang. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2020; 12(1): 92-100 doi: 10.4251/wjgo.v12.i1.92
|
| 2 |
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
|
| 3 |
Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6237-5
|
| 4 |
Jie‐Yu Yan, Jin‐Long Zhang, Mao‐Qiang Wang, Kai Yuan, Yan‐Hua Bai, Yan Wang, Hai‐Nan Xin, Zhi‐Jun Wang, Feng‐Yong Liu, Feng Duan, Jin‐Xin Fu. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single‐session for solitary hepatocellular carcinoma larger than 7 cm. Asia-Pacific Journal of Clinical Oncology 2018; 14(4): 300 doi: 10.1111/ajco.12817
|
| 5 |
Sae Hwan Lee. Curative Loco-regional Therapies for Early Hepatocellular Carcinoma: Is Combination Effective?. The Korean Journal of Gastroenterology 2019; 73(3): 121 doi: 10.4166/kjg.2019.73.3.121
|
| 6 |
Roberto Iezzi, Maurizio Pompili, Alessandro Posa, Giuseppe Coppola, Antonio Gasbarrini, Lorenzo Bonomo. Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. World Journal of Gastroenterology 2016; 22(6): 1935-1942 doi: 10.3748/wjg.v22.i6.1935
|
| 7 |
Wooil Kim, Sung Ki Cho, Sung Wook Shin, Dongho Hyun, Min Woo Lee, Hyunchul Rhim. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy. Abdominal Radiology 2019; 44(6): 2283 doi: 10.1007/s00261-019-01952-1
|
| 8 |
Enrico Boninsegna, Emilio Simonini, Stefano Crosara, Michela De Angelis, Luigi Boccia, Stefano Colopi. Large Multifocal Hepatocarcinoma: Technical Details of Treatment with Combined Transarterial Chemoembolization, Microwave and Radiofrequency Ablation. Journal of Gastrointestinal Cancer 2021; 52(1): 300 doi: 10.1007/s12029-020-00416-w
|
| 9 |
Guilin Zhang, Yanqiao Ren, Jiayun Liu, Yanyan Cao, Fu Xiong, Bin Liang, Chuansheng Zheng, Xuefeng Kan. Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis. Journal of Hepatocellular Carcinoma 2025; : 15 doi: 10.2147/JHC.S499763
|
| 10 |
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
|
| 11 |
Liangliang Yan, Yanqiao Ren, Kun Qian, Xuefeng Kan, Hongsen Zhang, Lei Chen, Bin Liang, Chuansheng Zheng. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01765-x
|
| 12 |
Ah Ran Kim, Eugene Park, So Young Kwon, Seong Jun Park, Young Jung Kim, Byung Chul Yoo, Won Hyeok Choe, Jeong Han Kim, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi hye Yu, Hae jeong Jeon. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment. The Korean Journal of Gastroenterology 2019; 73(3): 167 doi: 10.4166/kjg.2019.73.3.167
|
| 13 |
Hongjun Yuan, Fengyong Liu, Xin Li, Yang Guan, Maoqiang Wang. Angio-CT-Guided Transarterial Chemoembolization Immediately in Combination with Radiofrequency Ablation for Large Hepatocellular Carcinoma. Academic Radiology 2019; 26(2): 224 doi: 10.1016/j.acra.2018.04.007
|
| 14 |
Shiji Fang, Linqiang Lai, Jinyu Zhu, Liyun Zheng, Yuanyuan Xu, Weiqian Chen, Fazong Wu, Xulu Wu, Minjiang Chen, Qiaoyou Weng, Jiansong Ji, Zhongwei Zhao, Jianfei Tu. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.662366
|
| 15 |
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression. International Journal of Hyperthermia 2022; 39(1): 1 doi: 10.1080/02656736.2021.1998660
|
| 16 |
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-Fetoprotein. Clinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
|
| 17 |
Hong-Yu Wang, Gui-Xiong Zhang, Wen-Zhe Fan, Jin-Wei Li, Shu-Fang Hao, Yu-Shu Ouyang, Jia-Ping Li, Wen-Dao Liu. Simultaneous versus sequential transcatheter arterial chemoembolization combined with microwave ablation for hepatocellular carcinoma: A retrospective propensity score-matched analysis. Hepatobiliary & Pancreatic Diseases International 2025; doi: 10.1016/j.hbpd.2025.02.001
|
| 18 |
Yong Xie, Jian Wang, Yinghua Zou. Transarterial chemoembolization plus radiofrequency ablation: One of the effective interventions for hepatocellular carcinoma. iLIVER 2024; 3(3): 100114 doi: 10.1016/j.iliver.2024.100114
|
| 19 |
Mi Hye Yu, Young Jun Kim, Hee Sun Park, Sung Il Jung, Hae Jeong Jeon, Gianfranco D. Alpini. Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors. PLOS ONE 2019; 14(2): e0210667 doi: 10.1371/journal.pone.0210667
|
| 20 |
Jie Tan, René Michael Mathy, De-Hua Chang, Tian Tang, Zi-Shu Zhang, Yu-Dong Xiao. Combined transarterial iodized oil injection and computed tomography-guided thermal ablation for hepatocellular carcinoma: utility of the iodized oil retention pattern. Abdominal Radiology 2022; 47(1): 431 doi: 10.1007/s00261-021-03305-3
|
| 21 |
Yong Xie, Tianshi Lyu, Haitao Guan, Shoujin Cao, Li Song, Xiaoqiang Tong, Yinghua Zou, Jian Wang. Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1392495
|
| 22 |
Zongyi Yin, Dongying Chen, Shuang Liang, Xiaowu Li. Neoadjuvant Therapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 929 doi: 10.2147/JHC.S357313
|
| 23 |
Xin Zheng, Yanqiao Ren, Hanqing Hu, Kun Qian. Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.713432
|
| 24 |
Lin Zheng, Hai-Liang Li, Chen-Yang Guo, Su-Xia Luo. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. Korean Journal of Radiology 2018; 19(2): 237 doi: 10.3348/kjr.2018.19.2.237
|
| 25 |
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
|
| 26 |
Jae Min Park, Won Hyeok Choe, Jeong Han Kim, So Young Kwon, Byung Chul Yoo. The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma. Journal of Liver Cancer 2021; 21(2): 155 doi: 10.17998/jlc.2021.09.22
|